BioMarin (Phase III PARP) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
BioMarin (Phase III PARP) General Information
Description
Drugs for the treatment of breast cancer. The treatment specializes in orally-available poly ADP ribose polymerase (PARP)
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
- 770 Lindaro Street
- San Rafael, CA 94901
- United States
BioMarin (Phase III PARP) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioMarin (Phase III PARP) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|